Summary
- Profile Type
- Business request
- POD Reference
- BRPL20240826004
- Term of Validity
- 27 August 2024 - 27 August 2025
- Company's Country
- Poland
- Type of partnership
- Investment agreement
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
A leading health-tech company focused on revolutionising respiratory care flagship product, an AI-powered stethoscope, enabling accurate and real-time monitoring of lung and heart sounds from
the comfort of home is looking for investors and commercialisation partners. - Full Description
-
A leading health-tech company focused on revolutionising respiratory care flagship product, an AI-powered system that detects abnormalities in the respiratory system, enabling accurate and real-time monitoring of lung and heart sounds from the comfort of home is looking for investors and commercialisation partners.
With over 90% detection accuracy, the system empowers patients to manage their health effectively while providing healthcare professionals with reliable data for informed decision-making. Certified as a Class IIa medical device in the EU, the solution bridges the gap between home care and professional medical support, offering a user-friendly experience that enhances patient outcomes and reduces healthcare burdens. The company is committed to making advanced respiratory monitoring accessible to all, improving lives on a global scale. - Advantages and Innovations
-
1. Advanced AI Technology:● the solution leverages advanced AI algorithms trained on the world’s largest lung sound database, achieving 93% accuracy in detecting respiratory abnormalities. This ensures reliable detection of conditions like wheezes, rhonchi, and crackles, providing users with a comprehensive respiratory assessment.
2. Certified Medical Device: ● the device is certified as a Class IIa medical device in the EU, meeting stringent safety and efficacy standards. This certification underscores the device's reliability and builds trust among both users and healthcare professionals, making it a credible solution in the medical field.
3. User-Friendly Design: ● designed for non-medical users, the solution is easy to use at home. The accompanying mobile app guides users step-by-step through the monitoring process, making advanced respiratory care accessible to everyone.● the device provides immediate analysis and actionable insights, allowing users to take timely action based on accurate data. This reduces the need for frequent doctor visits and empowers users to manage their health more effectively.
4. Remote Healthcare Integration: ● the device integrates seamlessly with telemedicine platforms, enabling patients to share their health data with healthcare providers remotely. This enhances care coordination and allows for more efficient and informed medical decisions, particularly in managing chronic conditions like asthma and COPD.● by providing accurate, real-time data, the solution empowers both patients and doctors to make better-informed decisions, leading to improved health outcomes and more personalized care.
5. Accessibility and Convenience: ● the solution is readily available in consumer electronics stores, pharmacies, and online platforms, making it as accessible as other essential health tools like thermometers.● company offers a cost-effective solution for continuous respiratory monitoring, helping to reduce overall healthcare costs. - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
-
Investors: The company seeks investors who are not only interested in funding it’s growth but also share the vision of transforming respiratory care. The expected role of investors includes providing capital to accelerate our expansion, particularly in scaling production, enhancing marketing efforts, and entering new markets, such as the U.S. Investors will also play a strategic role by offering insights, guidance, and connections that can help the company navigate the complexities of global healthcare markets.
Commercialization Partners: The company is looking for commercialization partners who can help expand company’s presence in both B2B and B2C markets.
In the B2B space, the company seeks partners who specialize in medical devices and software distribution to healthcare providers, helping them integrate the device into clinics, hospitals, and telemedicine platforms.
For B2C, the company needs partners who can establish the device in consumer electronics stores, pharmacies, and Apple Premium Reseller stores. These partners will be responsible for local marketing, ensuring that this solution becomes a trusted and widely recognized product in their respective regions. Together, these partnerships will be crucial in making the company a global leader in respiratory health, ensuring their technology reaches those who need it most, while driving business growth and innovation - Type and Size of Partner
- SME 50 - 249
- SME 11-49
- SME <=10
- Big company
- Type of partnership
- Investment agreement
- Commercial agreement
Dissemination
- Technology keywords
- 06001013 - Medical Technology / Biomedical Engineering
- 01003003 - Artificial Intelligence (AI)
- 06005003 - Health information management
- 01004001 - Applications for Health
- 06005004 - Remote diagnostics
- Market keywords
- 07004002 - Health and beauty aids
- 05007007 - Other medical/health related (not elsewhere classified)
- 05001001 - Diagnostic services
- Targeted countries
- All countries